CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
496-510 of 1027
Expert Perspectives on Nonsteroidal MRAs and Cardiorenal Protection
CME/CEExpert Perspectives on Nonsteroidal MRAs and Cardiorenal Protection
Muthiah Vaduganathan, MD, MPH
Anu Lala, MD
Brendon Neuen, MBBS, PhD
Integrating IV Iron into Cancer Care: An Expert Overview of Best Practices
CME/CEIntegrating IV Iron into Cancer Care: An Expert Overview of Best Practices
Brian P. McDonough, MD, FAAFP
George M. Rodgers, MD, PhD
Patricia A. Ford, MD
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Bridging ASCVD Care Between Academic and Rural Settings
MinuteCE®Bridging ASCVD Care Between Academic and Rural Settings
Rishi Wadhera, MD, MPP, Mphil
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
MinuteCE®Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
- advertisement
Statins and Safety: What the Data Say About Dementia, Cancer, and More
MinuteCE®Statins and Safety: What the Data Say About Dementia, Cancer, and More
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
MinuteCE®Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
MinuteCE®Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
MinuteCE®The Dose Matters: Optimizing Statin Intensity in ASCVD Management
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
MinuteCE®Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
MinuteCE®Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
Rishi Wadhera, MD, MPP, Mphil
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- advertisement
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CEInnovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
Target in Sight: Escalating Therapy to Reach LDL-C Goals
MinuteCE®Target in Sight: Escalating Therapy to Reach LDL-C Goals
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CEChairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Darren Brenner, MD
